{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:13:43Z","timestamp":1780553623779,"version":"3.54.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"Supplement_7","license":[{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Vaccine herd protection is the extension of the defense conferred by immunization beyond the vaccinated to unvaccinated persons in a population, as well as the enhancement of the protection among the vaccinated, due to vaccination of the surrounding population. Vaccine herd protection has traditionally been inferred from observations of disease trends after inclusion of a vaccine in national immunization schedules. Rather than awaiting outcomes of widescale vaccine deployment, earlier-stage evaluation of vaccine herd protection during trials or mass vaccination projects could help inform policy decisions about potential vaccine introduction. We describe the components, influencing factors, and implications of vaccine herd protection and discuss various methods for assessing herd protection, using examples from cholera and typhoid vaccine studies.<\/jats:p>","DOI":"10.1093\/infdis\/jiab358","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T11:08:58Z","timestamp":1625656138000},"page":"S764-S769","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of Vaccine Herd Protection: Lessons Learned From Cholera and Typhoid Vaccine Trials"],"prefix":"10.1093","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8875-5026","authenticated-orcid":false,"given":"Jacqueline","family":"Deen","sequence":"first","affiliation":[{"name":"Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Clemens","sequence":"additional","affiliation":[{"name":"International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh"},{"name":"Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,17]]},"reference":[{"key":"2021122015211934500_CIT0001","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1473-3099(10)70318-2","article-title":"New approaches to the assessment of vaccine herd protection in clinical trials","volume":"11","author":"Clemens","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2021122015211934500_CIT0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2021122015211934500_CIT0003","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/oxfordjournals.aje.a115884","article-title":"Direct and indirect effects in vaccine efficacy and effectiveness","volume":"133","author":"Halloran","year":"1991","journal-title":"Am J Epidemiol"},{"key":"2021122015211934500_CIT0004","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.provac.2010.07.005","article-title":"Concepts of herd protection and immunity","volume":"2","author":"Smith","year":"2010","journal-title":"Procedia Vaccinol"},{"key":"2021122015211934500_CIT0005","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","article-title":"Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative","volume":"150","author":"Fine","year":"1999","journal-title":"Am J Epidemiol"},{"key":"2021122015211934500_CIT0006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/cid\/ciq001","article-title":"Implementation of cocooning against pertussis in a high-risk population","volume":"52","author":"Healy","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021122015211934500_CIT0007","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.294.2.202","article-title":"Incidence of hepatitis A in Israel following universal immunization of toddlers","volume":"294","author":"Dagan","year":"2005","journal-title":"JAMA"},{"key":"2021122015211934500_CIT0008","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(05)66788-8","article-title":"Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study","volume":"366","author":"Adegbola","year":"2005","journal-title":"Lancet"},{"key":"2021122015211934500_CIT0009","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"2021122015211934500_CIT0010","doi-asserted-by":"crossref","first-page":"e00309","DOI":"10.1128\/mBio.00309-10","article-title":"Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States","volume":"2","author":"Simonsen","year":"2011","journal-title":"mBio"},{"key":"2021122015211934500_CIT0011","first-page":"477","article-title":"Cholera vaccines: WHO position paper\u2014August 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"2021122015211934500_CIT0012","first-page":"153","article-title":"Typhoid vaccines: WHO position paper\u2014March 2018","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"2021122015211934500_CIT0013","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0040336","article-title":"Controlling endemic cholera with oral vaccines","volume":"4","author":"Longini","year":"2007","journal-title":"PLoS Med"},{"key":"2021122015211934500_CIT0014","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/infdis\/jiy487","article-title":"Progress and challenges in using oral cholera vaccines to control outbreaks: the M\u00e9decins Sans Fronti\u00e8res experience","volume":"218","author":"Ciglenecki","year":"2018","journal-title":"J Infect Dis"},{"key":"2021122015211934500_CIT0015","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(18)30350-5","article-title":"Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance","volume":"19","author":"Andrews","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021122015211934500_CIT0016","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/cid\/cir007","article-title":"\u201cHerd immunity\u201d: a rough guide","volume":"52","author":"Fine","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021122015211934500_CIT0017","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fpubh.2019.00211","article-title":"Assessing vaccine herd protection by killed whole-cell oral cholera vaccines using different study designs","volume":"7","author":"Ali","year":"2019","journal-title":"Front Public Health"},{"key":"2021122015211934500_CIT0018","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","article-title":"Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis","volume":"12","author":"Jeuland","year":"2009","journal-title":"Value Health"},{"key":"2021122015211934500_CIT0019","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/INF.0b013e318149dffd","article-title":"Vaccine protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission","volume":"27","author":"Ali","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"2021122015211934500_CIT0020","first-page":"166","article-title":"Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings","volume":"87","author":"Diaz","year":"1991","journal-title":"Pediatrics"},{"key":"2021122015211934500_CIT0021","doi-asserted-by":"crossref","first-page":"20162562","DOI":"10.1098\/rspb.2016.2562","article-title":"Why does drug resistance readily evolve but vaccine resistance does not?","volume":"284","author":"Kennedy","year":"2017","journal-title":"Proc R Soc B Biol Sci"},{"key":"2021122015211934500_CIT0022","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.epirev.a036121","article-title":"Herd immunity: history, theory, practice","volume":"15","author":"Fine","year":"1993","journal-title":"Epidemiol Rev"},{"key":"2021122015211934500_CIT0023","doi-asserted-by":"crossref","first-page":"18977","DOI":"10.1038\/s41598-020-75691-5","article-title":"Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency","volume":"10","author":"L\u00f8chen","year":"2020","journal-title":"Sci Rep"},{"key":"2021122015211934500_CIT0024","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/0141076815582303","article-title":"A brief history of the cluster randomised trial design","volume":"108","author":"Moberg","year":"2015","journal-title":"J R Soc Med"},{"key":"2021122015211934500_CIT0025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2105\/AJPH.94.3.416","article-title":"Pitfalls of and controversies in cluster randomization trials","volume":"94","author":"Donner","year":"2004","journal-title":"Am J Public Health"},{"key":"2021122015211934500_CIT0026","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"key":"2021122015211934500_CIT0027","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/inthealth\/ihz069","article-title":"Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial","volume":"12","author":"Ali","year":"2020","journal-title":"Int Health"},{"key":"2021122015211934500_CIT0028","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1016\/j.vaccine.2012.06.015","article-title":"Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan","volume":"30","author":"Khan","year":"2012","journal-title":"Vaccine"},{"key":"2021122015211934500_CIT0029","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/oxfordjournals.aje.a113261","article-title":"Randomization by cluster. Sample size requirements and analysis","volume":"114","author":"Donner","year":"1981","journal-title":"Am J Epidemiol"},{"key":"2021122015211934500_CIT0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/oxfordjournals.aje.a009196","article-title":"Study designs for evaluating different efficacy and effectiveness aspects of vaccines","volume":"146","author":"Halloran","year":"1997","journal-title":"Am J Epidemiol"},{"key":"2021122015211934500_CIT0031","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/(SICI)1097-0258(19980530)17:10<1121::AID-SIM824>3.0.CO;2-E","article-title":"Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations","volume":"17","author":"Longini","year":"1998","journal-title":"Stat Med"},{"key":"2021122015211934500_CIT0032","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/096228020000900203","article-title":"Design and analysis issues in cluster-randomized trials of interventions against infectious diseases","volume":"9","author":"Hayes","year":"2000","journal-title":"Stat Methods Med Res"},{"key":"2021122015211934500_CIT0033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"key":"2021122015211934500_CIT0034","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2021122015211934500_CIT0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.inf.0000109248.32907.1d","article-title":"Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias","volume":"23","author":"Shapiro","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2021122015211934500_CIT0036","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3201\/eid2206.151592","article-title":"Population-level effect of cholera vaccine on displaced populations, South Sudan, 2014","volume":"22","author":"Azman","year":"2016","journal-title":"Emerg Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab358\/39074123\/jiab358.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_7\/S764\/41826173\/jiab358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_7\/S764\/41826173\/jiab358.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T15:23:09Z","timestamp":1640013789000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/224\/Supplement_7\/S764\/6323356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,17]]},"references-count":36,"journal-issue":{"issue":"Supplement_7","published-online":{"date-parts":[[2021,7,17]]},"published-print":{"date-parts":[[2021,12,20]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab358","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,15]]},"published":{"date-parts":[[2021,7,17]]}}}